Use of Novel Mobile Technology to Screen Sexual Partners for HIV and STIs

使用新型移动技术筛查性伴侣的艾滋病毒和性传播感染

基本信息

项目摘要

 DESCRIPTION (provided by applicant): Increasing incidence of HIV and STIs among men who have sex with men (MSM) and transgender women (TGW) highlight the need for novel approaches to reducing infections-especially among individuals who do not use condoms consistently. Our prior studies on the use of rapid HIV self-testing (ST) by MSM who regularly engage in high-risk sexual behavior, show that these men are willing to use ST with partners, avoid intercourse in situations where partners test HIV-positive, and, over time tend to reduce their high-risk sexual behavior. This proposed study expands this line of research by exploring the use of a new device, the mChip dongle. Developed at the Columbia University School of Engineering, this device uses smartphone technology to analyze a drop of blood and test it for HIV and syphilis antibodies. The mChip dongle brings more precision to ST, tests for HIV and syphilis and potentially other STIs, and can capitalize on smartphone technology to provide clearer user instructions, on-hand information about HIV/STI, remote monitoring of the its use, and linkage of newly diagnosed individuals to care. For this proposed quantitative and qualitative study, we will again focus on HIV-uninfected MSM and TGW with multiple sexual partners who know how to prevent HIV infection, yet engage in high-risk sexual behavior. The Specific Aims are to: 1) Assess acceptability among MSM and TGW of using the mChip dongle to test sexual partners; 2) Optimize the smartphone app and mChip dongle for home use; and 3) Assess the feasibility of using the mChip dongle to test sexual partners, including: a) frequency of use of the mChip dongle with sexual partners over 3 months; b) factors associated with mChip dongle use or non-use; c) condom use with partners who were not screened vs. partners screened HIV or STI- negative with the mChip dongle; and d) factors associated with changes in sexual risk behavior over 3 months. The study consists of two phases. In Phase 1A, 60 participants will undergo a quantitative, qualitative, and skill-demonstration assessment (using the mChip dongle in front of the interviewer) in a single study visit. Phase 1A findings wil inform Phase 1B, which focuses on revising the smartphone app and mChip dongle for home users, as well as revisions to the Phase 2 assessment. In Phase 2A, 80 new participants will undergo a baseline quantitative and skill-demonstration assessment in order to screen for 50 participants who will be invited into the Phase 2B 3-month study. These 50 participants will be provided with an mChip dongle and given the choice to use it to screen sexual partners. After 3 months participants will undergo a quantitative and qualitative interview about experiences using (or not using) the mChip dongle with partners. This study will capitalize on a critical juncture in the development of the mChip dongle by systematically engaging its intended users in offering feedback to the engineering team on how to optimize its usability and acceptability among high-risk populations. This study will also allow us to assess the feasibility of conducting a larger and longer trial to develop and test an mChip-based harm-reduction intervention.
 描述(由申请人提供):男男性行为者(MSM)和变性妇女(TGW)中艾滋病毒和性传播感染的发病率不断增加,这突出表明需要采取新的方法来减少感染,特别是在不经常使用避孕套的人群中。我们以前的研究使用快速艾滋病毒自我检测(ST)的男男性接触者经常从事高风险的性行为,表明这些人愿意使用ST与合作伙伴,避免性交的情况下,合作伙伴测试艾滋病毒呈阳性,并随着时间的推移,往往会减少他们的高风险性行为。这项拟议的研究通过探索使用一种新设备mChip加密狗来扩展这一研究领域。该设备由哥伦比亚大学工程学院开发,使用智能手机技术分析一滴血,并检测其是否含有艾滋病毒和梅毒抗体。mChip加密狗为ST、艾滋病毒和梅毒以及潜在的其他性传播感染测试带来了更高的精度,并可以利用智能手机技术提供更清晰的用户说明、关于艾滋病毒/性传播感染的现有信息、对其使用的远程监控以及新诊断个人与护理的联系。在这项定量和定性研究中,我们将再次关注未感染HIV的MSM和TGW,他们有多个性伴侣,知道如何预防HIV感染,但从事高危性行为。具体目标是:1)评估MSM和TGW使用mChip加密狗测试性伴侣的可接受性; 2)优化智能手机应用程序和mChip加密狗以供家庭使用;以及3)评估使用mChip加密狗测试性伴侣的可行性,包括:a)性伴侣在3个月内使用mChip加密狗的频率; B)与mChip加密狗使用或不使用相关的因素; c)未筛查的伴侣与使用mChip加密狗筛查HIV或STI阴性的伴侣使用避孕套;以及d)与3个月内性风险行为变化相关的因素。研究分为两个阶段。在第1A阶段,60名参与者将在一次研究访问中接受定量,定性和技能演示评估(在面试官面前使用mChip加密狗)。第1A阶段的调查结果将为第1B阶段提供信息,第1B阶段的重点是为家庭用户修改智能手机应用程序和mChip加密狗,以及对第2阶段评估的修改。在2A期,80名新受试者将接受基线定量和技能演示评估,以筛选50名受试者,这些受试者将被邀请参加2B期3个月研究。这50名参与者将获得一个mChip加密狗,并可以选择使用它来筛选性伴侣。3个月后,参与者将接受定量和定性访谈,了解与合作伙伴使用(或不使用)mChip加密狗的体验。 本研究将利用mChip加密狗开发的关键时刻,系统地让其预期用户向工程团队提供关于如何优化其在高风险人群中的可用性和可接受性的反馈。这项研究还将使我们能够评估进行更大规模和更长时间试验的可行性,以开发和测试基于mChip的减少伤害干预措施。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ivan C Balan其他文献

Ivan C Balan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ivan C Balan', 18)}}的其他基金

Integration of Electronic SBI(RT) into an HIV Testing Program to Reduce Substance Use and HIV risk Behavior among MSM in Argentina
将电子 SBI(RT) 纳入 HIV 检测计划,以减少阿根廷 MSM 的药物使用和 HIV 风险行为
  • 批准号:
    10402058
  • 财政年份:
    2022
  • 资助金额:
    $ 57.69万
  • 项目类别:
Integration of Electronic SBI(RT) into an HIV Testing Program to Reduce Substance Use and HIV risk Behavior among MSM in Argentina
将电子 SBI(RT) 纳入 HIV 检测计划,以减少阿根廷 MSM 的药物使用和 HIV 风险行为
  • 批准号:
    10669561
  • 财政年份:
    2022
  • 资助金额:
    $ 57.69万
  • 项目类别:
Use of Novel Mobile Technology to Screen Sexual Partners for HIV and STIs
使用新型移动技术筛查性伴侣的艾滋病毒和性传播感染
  • 批准号:
    9270044
  • 财政年份:
    2016
  • 资助金额:
    $ 57.69万
  • 项目类别:
Use of Novel Mobile Technology to Screen Sexual Partners for HIV and STIs
使用新型移动技术筛查性伴侣的艾滋病毒和性传播感染
  • 批准号:
    9133042
  • 财政年份:
    2016
  • 资助金额:
    $ 57.69万
  • 项目类别:
HIV-Prevention Intervention Targets in High-risk Alcohol Venues in Argentina
阿根廷高风险酒精场所的艾滋病毒预防干预目标
  • 批准号:
    7620532
  • 财政年份:
    2008
  • 资助金额:
    $ 57.69万
  • 项目类别:
HIV-Prevention Intervention Targets in High-risk Alcohol Venues in Argentina
阿根廷高风险酒精场所的艾滋病毒预防干预目标
  • 批准号:
    7694321
  • 财政年份:
    2008
  • 资助金额:
    $ 57.69万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 57.69万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 57.69万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 57.69万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 57.69万
  • 项目类别:
    Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 57.69万
  • 项目类别:
    Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 57.69万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 57.69万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
  • 批准号:
    10639161
  • 财政年份:
    2023
  • 资助金额:
    $ 57.69万
  • 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
  • 批准号:
    10752441
  • 财政年份:
    2023
  • 资助金额:
    $ 57.69万
  • 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
  • 批准号:
    10867639
  • 财政年份:
    2023
  • 资助金额:
    $ 57.69万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了